Samsara BioCapital, L.P.

Holdings History for Mineralys Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MLYS)

Symbol: MLYS on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 6,346,194 shares
Security Ownership %: 8.2%

Srinivas Akkaraju ownership in Mineralys Therapeutics, Inc. Common Stock, par value $0.0001 per share (MLYS)

08 Sep 2025 - Srinivas Akkaraju has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,346,194 shares of Mineralys Therapeutics, Inc. Common Stock, par value $0.0001 per share (MLYS). This represents 8.2% ownership of the company. In their previous filing dated 17 Mar 2025, Samsara BioCapital, L.P. had reported owning 5,736,305 shares, indicating an increase of +11%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Srinivas Akkaraju	8.2%	-10%	$85,419,771	6,346,194	+609,889	+11%	$13.46	13D/A	04 Sep 2025	08 Sep 2025, 20:05
Srinivas Akkaraju	9.1%		$77,784,296	5,736,305			$13.56	13D/A	13 Mar 2025	17 Mar 2025, 21:06